4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-015453
Chief Financial Officer sold 11,176 shares at $8.25 ($92,202)
- Chief Financial Officer acquired 11,176 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-03-15 | Option exercise | +11,176 | $4.69 | $52,415 | 261,246 | D |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-03-15 | Sale | −11,176 | $8.25 | $92,202 | 250,070 | D |
| Derivatives | |||||||
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-03-15 | Option exercise · Stock Option (Right to Buy) | −11,176 | 24,920 | D | ||
| Open-market sales · 11,176 sh · avg $8.25 · $92,202 | |||||||
Loading xslF345X03/tv488826_4.xml…